Clinical Trial Update: Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates that the Phase 1/Phase 2 safety and feasibility study of autologous stromal vascular fraction (SVF) cells for osteoarthritis h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Autologous stromal vascular fraction (SVF) cells

Snippet

Sponsor: Translational Biosciences | Conditions: Osteoarthritis | Phase 1, Phase 2 | Status: WITHDRAWN